Barry J. Schindler is the Chair of Greenberg Traurig's Global Patent Prosecution Group -- a group of approximately 4,000 domestic and 4,100 foreign applications pending and over 100 attorneys, who are registered with the USPTO. Barry has more than twenty-five years of legal experience in all aspects of pharmaceutical and chemical patent prosecution -- representing numerous major pharmaceutical and chemical companies regarding patents relating to small molecules and synthetic compounds.
Barry has helped companies of all sizes build and manage large patent portfolios, develop in-house procedures, and formulate intellectual property strategies. Barry positions clients to gain a competitive advantage by identifying patentable subject matter and drafting claims and providing patent opinions in such a way that infringement becomes possible to prove.
Barry has worked in numerous patent litigations to develop an overall case strategy that involves complementing a litigation strategy with actions at the USPTO. Barry has been involved in dozens of reexamination proceedings and over 50 IPR proceedings at the USPTO. He has worked with the USPTO in setting up numerous technical fairs, seminars and meetings to further the education of the Examiners.
Barry, an active member of the firm's Israel Practice also focuses his practice on managing the patent portfolio for numerous innovative Israeli start-ups. Barry is a frequent business visitor to Israel and is very involved with the local tech community.